脑氧饱和度联合α变异百分比对创伤性脑损伤患者脑功能预后的早期评估价值
该回顾性分析纳入2018年8月至2019年7月河南省人民医院ICU收治的42例创伤性脑损伤患者,记录伤后72小时内rScO2、PAV和GCS评分,以3个月GOS评分1-3分为不良预后组(18例)、4-5分为良好预后组(24例)。不良预后组rScO2 III级、PAV III级、GCS III级占比均显著高于良好预后组。多因素Logistic回归显示rScO2(OR=4.656,95%CI 1.071-20.233)和PAV(OR=3.525,95%CI 1.044-11.906)为独立危险因素。rScO2、PAV单独预测AUC分别为0.796和0.780,联合预测AUC为0.851,敏感度94.4%、特异度62.5%。
要点
- 42例TBI患者伤后72小时内rScO2 III级(<0.50)者不良预后占55.6%(10/18),良好预后仅8.3%(2/24),差异有统计学意义。
- PAV III级(1分)者不良预后占38.9%(7/18),良好预后占8.4%(2/24),差异有统计学意义。
- rScO2为脑功能预后独立危险因素(OR=4.656,95%CI 1.071-20.233,P=0.040),PAV亦为独立危险因素(OR=3.525,95%CI 1.044-11.906,P=0.042)。
- rScO2联合PAV预测3个月不良预后的AUC为0.851,高于rScO2单独(0.796)或PAV单独(0.780),敏感度94.4%、特异度62.5%。
适用人群与场景
- 2018年8月至2019年7月河南省人民医院ICU收治、同时监测rScO2和床旁定量脑电图的创伤性脑损伤患者,共42例。
诊断标准与关键阈值
- rScO2分级:≥0.60为I级,0.50≤rScO2<0.60为II级,<0.50为III级。
- PAV分级:3-4分为I级,2分为II级,1分为III级。
- GCS分级:9-14分为I级,4-8分为II级,3分为III级。
- 预后判定:3个月GOS评分1-3分为脑功能不良预后,4-5分为良好预后。
研究设计与关键结果
- 回顾性分析,42例TBI患者,rScO2 I级14例、II级16例、III级12例;PAV I级16例、II级17例、III级9例;GCS I级13例、II级23例、III级6例;不良预后18例、良好预后24例。
- 不良预后组rScO2 III级占比高于良好预后组[55.6%(10/18)vs. 8.3%(2/24)],差异有统计学意义(P<0.05)。
- 不良预后组PAV III级占比高于良好预后组[38.9%(7/18)vs. 8.4%(2/24)],差异有统计学意义(P<0.05)。
- 不良预后组GCS III级占比高于良好预后组[27.7%(5/18)vs. 4.1%(1/24)],差异有统计学意义(P<0.05)。
- 两组性别、年龄、总住院时间、APACHE II评分等一般资料差异无统计学意义。
- 多因素Logistic回归:rScO2为独立危险因素(OR=4.656,95%CI 1.071-20.233,P=0.040),PAV为独立危险因素(OR=3.525,95%CI 1.044-11.906,P=0.042)。
- ROC曲线:rScO2预测AUC=0.796(P<0.01),PAV预测AUC=0.780(P<0.01),二者联合AUC=0.851(P<0.01),敏感度94.4%、特异度62.5%。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为rScO2与PAV与TBI患者早期脑功能预后相关,二者联合可较可靠地评估TBI患者脑功能预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the usability of regional saturation of cerebral oxygenation (rScO2) combined with percentage of α variability (PAV) in predicting brain function prognosis in patients with traumatic brain injury (TBI).
METHODS: A retrospective analysis was conducted. The clinical data of patients with TBI who were monitored rScO2 and bedside quantitative electroencephalogram (qEEG) admitted to intensive care unit (ICU) of Henan Provincial People's Hospital from August 2018 to July 2019 were collected. The rScO2, PAV, and Glasgow coma scale (GCS) score were recorded within 72 hours after the TBI. The primary prognostic indicator was the 3-month Glasgow outcome score (GOS) score. The differences between the two groups of poor prognosis of brain function (GOS score 1-3) and good prognosis (GOS score 4-5) were compared. Binary multivariate Logistic regression analysis was used to analyze the correlation between rScO2, PAV, GCS score and the prognosis of brain function in patients with TBI. In addition, receiver operating characteristic (ROC) curve was plotted to analyze the predicting value of rScO2 and PAV only or combination for prognosis of brain function.
RESULTS: A total of 42 patients with TBI were enrolled in the study, with rScO2 ≥ 0.60 (grade I) in 14 patients, 0.50 ≤ rScO2 < 0.60 (grade II) in 16 patients, and rScO2 < 0.50 (grade III) in 12 patients. PAV 3-4 scores (grade I) were detected in 16 patients, 2 scores (grade II) in 17 patients, and 1 score (grade III) in 9 patients. GCS score 9-14 (grade I) were observed in 13 patients, 4-8 (grade II) in 23 patients, and 3 (grade III) in 6 patients; 18 patients had poor prognosis and 24 had good one. The rScO2, PAV and GCS scores of the poor-prognosis group were significantly higher than those in the good-prognosis group [rScO2 with grade III: 55.6% (10/18) vs. 8.3% (2/24), PAV with grade III: 38.9% (7/18) vs. 8.4% (2/24), GCS score with grade III: 27.7% (5/18) vs. 4.1% (1/24)] with significant differences (all P < 0.05). There was no significant difference in other general data including gender, age, total length of hospital stay or acute physiology and chronic health evaluation II (APACHE II) score between the two groups. Binary multivariate Logistic regression analysis showed that rScO2 and PAV were independent risk factors for prognosis of brain in patients with TBI [rScO2: odds ratio (OR) = 4.656, 95% confidence interval (95%CI) was 1.071-20.233, P = 0.040; PAV: OR = 3.525, 95%CI was 1.044-11.906, P = 0.042]. ROC curve analysis showed that both of rScO2 and PAV had predictive value for the prognosis of brain function in patients with TBI (AUC was 0.796 and 0.780, respectively, both P < 0.01), and rScO2 combined with PAV had higher predictive value with the AUC of 0.851 (P < 0.01) than rScO2 or PAV alone, the sensitivity was 94.4% and the specificity was 62.5%.
CONCLUSIONS: rScO2 and PAV were associated with early brain function prognosis in patients with TBI. The combination of two monitoring indicators can reliably assess the prognosis of brain function in patients with TBI.
参考来源
- Wang X, Shao H, Wang C, et al. [Early assessment value of brain function prognosis in patients with traumatic brain injury by regional saturation of cerebral oxygenation combined with percentage of α variability]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31898567. doi:10.3760/cma.j.issn.2095-4352.2019.11.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。